DOJ Lawyer Admits FDA War Against Ivermectin Was Abuse of Authority
The attorney from the Department of Justice who defended the Food and Drug Administration in court admitted on undercover camera that the agency’s actions were an abuse of authority by the government during its public campaign against ivermectin to treat COVID-19. The FDA’s “horse medicine” tweets caused a deadly chain reaction. Meet Drs. Mary Talley […]
FDA Removes Social Media Posts Against Ivermectin, Settles Lawsuit
The U.S. Food and Drug Administration (FDA) and the U.S. Department of Health and Human Services (HHS) have agreed to remove social media posts and web pages cautioning the public not to take the FDA-approved drug Ivermectin to treat COVID-19 symptoms. The move comes as part of lawsuit settlement. In 2022, three doctors, Drs. Mary […]
Federal Court Sides With Doctors on Ivermectin Lawsuit Charging FDA Overreach
The Fifth Circuit Court of Appeals in New Orleans has given new life to a lawsuit brought by three doctors claiming the U.S. Food and Drug Administration (FDA) overstepped its authority and acted as a medical doctor rather than as a regulating authority in the agency’s campaign promoting a ban on the use of the […]
One-Third of Adults Polled Think COVID Shots Killed Thousands
A recent poll released by KFF (formerly Kaiser Family Foundation) of San Francisco, California on Aug. 22, 2023 found that one-third of adults in the United States believe that the COVID-19 shots “caused thousands of sudden deaths in otherwise healthy people.” Ten percent of that one-third believe it is “definitely true” that the shots killed thousands […]
Treatment Protocols for COVID-19: An Overview
Two years into the global pandemic of the novel coronavirus SARS-CoV-2, there is scant guidance from government agencies, universities, or professional medical organizations to help individuals recover from the SARS-CoV-2 infection that causes COVID-19 without the need for hospitalization. The U.S. Centers for Disease Control and Prevention (CDC), which recommends monoclonal antibodies for high-risk individuals […]